Top Markets
#1 Ontology Gas Ontology Gas +45.91%
#2 Verus Coin Verus Coin +22.51%
#3 EXOD EXOD +22.08%
#4 Status Status +20.01%
#5 ETHGas ETHGas +18.84%
#6 Geodnet Geodnet +16.73%
#7 The Black Bull The Black Bull +16.27%
#8 Derive Derive +11.24%
#9 Fake World Assets Fake World Assets +11.05%
#10 Ontology Ontology +8.69%
Coin of the day
Ontology Gas Ontology Gas
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Promore Pharma AB (publ) Promore Pharma AB (publ)

Promore Pharma AB (publ)

PROMO
Rangering i aksjer #25506
Promore Pharma AB (publ) is a Swedish biopharmaceutical firm dedicated to... Promore Pharma AB (publ) is a Swedish biopharmaceutical firm dedicated to advancing peptide-based drug therapies. The company's development pipeline features PXL01, currently undergoing Phase IIa studies for its potential in preventing post-surgical adhesions and scars, mitigating dermal scarring, and aiding hand tendon repair. Another key asset, LL-37, is engaged in Phase IIb clinical trials to address venous leg ulcers, stimulate the healing of persistent wounds, and treat diabetic foot ulcers. Additionally, Promore Pharma has partnered with Fidia Farmaceutici S.p.A. for the production of hyaluronic acid syringes. Founded in 2002, the company, formerly known as Lipopeptide AB until its rebranding in January 2017, maintains its headquarters in Solna, Sweden.
Aksjekurs
$1.34
Sist synkronisert: 2024-02-14
Markedsverdi
$48.96M
Endring (1 dag)
-12.94%
Endring (1 år)
0.00%
Land
SE
Handel Promore Pharma AB (publ) (PROMO)

Kategori

Healthcare
P/B-forhold for Promore Pharma AB (publ) (PROMO)
P/B-forhold per 2026 TTM: 0
Ifølge Promore Pharma AB (publ) sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/B-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/B-forhold på 0.
P/B-historikk for Promore Pharma AB (publ) fra 2026 til 2026
P/B-forhold ved hvert års slutt
År P/B-forhold Endre
Ikke nok data for de angitte datoene.
P/B-forhold for lignende selskaper eller konkurrenter
Selskap P/B-forhold Forskjell i P/B-forhold Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 3.7087 -
US